IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models-Reference-Cited by-同舟云学术

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models

Published:2024-01 Issue: Volume:199 Page:106998
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Yaden David B.,Berghella Andrea P.,Hendricks Peter S.,Yaden Mary E.,Levine Michael^ORCID,Rohde Julia S.^ORCID,Nayak Sandeep,Johnson Matthew W.,Garcia-Romeu Albert^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference127 articles.

1. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5–year update;Andrilla;J. Rural Health,2019

2. The tripping point: the potential role of psychedelic-assisted therapy in the response to the opioid crisis;Argento;Int. J. Drug Policy,2019

3. Psychedelic knowledge and opinions in psychiatrists at two professional conferences: an exploratory survey;Barnett;J. Psychoact. Drugs,2022

4. Cognitive therapy: Basics and beyond (No. Sirsi) i9780898628470);Beck,1995

5. Management of opioid use disorder in the USA: present status and future directions;Blanco;Lancet,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychedelic public health: State of the field and implications for equity;Social Science & Medicine;2024-09

2. Hitting the Reset Button: Ceremonial Use of Peyote and Experiences of Personal Change;Journal of Drug Issues;2024-08-22

3. Navigating the “Psychedelic Renaissance”: From Research to Reality;International Journal of Mental Health and Addiction;2024-04